ABVC BioPharma's ADHD and MDD Drug Polygala Tenuifolia a Natural Wonder With Potential of Transforming Mental Health Treatment of More Than 30 Billion Market Jan. 15, 2025 8:30 AM ET Source: ABVC BioPharma, Inc.
Shrihari Allangala Joins Blackwell 3D Board, Set to Lead Growth and Strategic Expansion of Consulting Division Jan. 10, 2025 8:56 AM ET Source: Blackwell 3D construction Corporation
ABVC BioPharma and ForSeeCon: An Update on Alliance's Ophthalmology-Related Products Jan. 7, 2025 8:30 AM ET Source: ABVC BioPharma, Inc.
Aemetis Biogas Commissioned Three New Dairy Digesters in December 2024, Increasing Expected RNG Production Capacity by 80% to 550,000 MMBtu Per Year for 2025 Jan. 7, 2025 8:00 AM ET Source: Aemetis, Inc.
ABVC BioPharma Secures an Additional Patent for ADHD Treatment, in Addition to the Granted U.S. and Australian Patents, Moving Forward to the Global Patent Map of $32.14 Billion Potential Market Jan. 2, 2025 9:00 AM ET Source: ABVC BioPharma, Inc.
Innovative Designs Inc. Reports Record Sales Results to Shareholders Dec. 30, 2024 10:09 AM ET Source: Innovative Designs Inc.
Blackwell 3D Reflects on Transformative 2024 and Announces Ambitious Goals for 2025 Dec. 20, 2024 8:52 AM ET Source: Blackwell 3D construction Corporation
Aemetis Registrations Approved by the IRS for 45Z Production Tax Credits Dec. 17, 2024 8:00 AM ET Source: Aemetis, Inc.
